CompletedPhase 4

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

United States21 participantsStarted 2004-03

Plain-language summary

The purpose of this study is to collect data on patients with severe uveitis that have required re-implantation of the sustained-release fluocinolone drug delivery device due to depletion of study drug in their previous implanted device.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Non-infectious intermediate, posterior or panuveitis * Previous placement of fluocinolone acetonide implant with initial uveitis quiescence and subsequent recurrence of inflammation once implant depleted of drug Exclusion Criteria: * Infectious uveitis

What they're measuring

Number of Eyes With Inflammation Recurrence

Timeframe: 5 years

Trial details

NCT IDNCT00543296

SponsorDuke University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2007-07

Results submitted2013-08-08

View on ClinicalTrials.gov More Uveitis trials